AC Immune pops in trading debut

Neurodegeneration company AC Immune S.A. (NASDAQ:ACIU) gained $4.66 (42%) to $15.66 on Friday in its first day of trading after raising $66 million in an IPO underwritten by Credit Suisse, Jefferies and Leerink (see BioCentury Extra, Sept. 22).

The listing price valued AC Immune at $609.4 million. It ended the day with a market cap of $867.5 million. ...